Antioxidant status in the aqueous humour of patients with glaucoma associated with exfoliation syndrome

Eye

Volumn 23, Issue 8, 2009, Pages 1691-1697

  Ferreira, S M ^a   Lerner, S F ^a   Brunzini, R ^a   Evelson, P A ^a,b   Llesuy, S F ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Antioxidants; Aqueous humour; Glaucoma associated with exfoliation syndrome; Oxidative stress; Primary open angle glaucoma

Indexed keywords

ASCORBIC ACID; CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; AQUEOUS HUMOR; ARTICLE; CATARACT; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; EXFOLIATION SYNDROME; HUMAN; OPEN ANGLE GLAUCOMA; SPECTROPHOTOMETRY;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; AQUEOUS HUMOR; ASCORBIC ACID; CATALASE; CATARACT; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; GLUTATHIONE PEROXIDASE; HUMANS; LUMINESCENCE; MALE; SUPEROXIDE DISMUTASE;

EID: 69049086944     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.352     Document Type: Article

References (50)

1. Ritch R. Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J Glaucoma 1994; 3: 176-178. (Pubitemid 24179802)
2. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001; 45: 265-315.
3. Naumann G, Schlötzer-Schrehardt U, Küchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmol 1998; 105: 951-968.
4. Schlötzer-Schrehardt U, Koca MR, Naumann G. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992; 110: 1752-1756.
5. Schlötzer-Schrehardt U, Naumann G. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006; 141: 921-937.
6. Koliakos G, Schöltzer-Schrehardt U, Konstas AG, Bufidis T, Georgiadis N, Dimitriadou A. Transforming and insulinlike growth factors in the aqueous humor of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2001; 239: 482-487. (Pubitemid 32733963)
7. Schöltzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas A, Naumann G. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with exfoliation syndrome glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003; 44: 1117-1125. (Pubitemid 36300758)
8. Koliakos G, Konstas A, Triantos A, Ritch R. Increased growth factor activity in the aqueous humor of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2000; 238: 491-495. (Pubitemid 30420868)
9. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine, 3rd ed. Oxford University Press Inc: Oxford, UK, 1989.
10. Sies H. Oxidative Stress. Academic Press: San Diego, 1985.
11. Richer SP, Rose RC. Water soluble antioxidants in mammalian aqueous humor. Interaction with UV and hydrogen peroxide. Vis Res 1998; 38: 2881-2888.
12. Tso M. Retinal photic injury in normal and scorbutic monkeys. Trans Am Ophthalmol Soc 1987; 85: 498-556. (Pubitemid 18080686)
13. Rose R, Bode A. Ocular ascorbate transport and metabolism. Comp Biochem Pharm 1991; 100: 273-285.
14. Garland D. Ascorbic acid and the eye. Am J Clin Nutr 1991; 54: 1193-1202.
15. Varma SD. Ascorbic acid and the eye with special reference to the lens. NY Acad Sci 1987; 498: 280-306.
16. Varma SD. Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr 1991; 53: 335-345.
17. Reddy VN, Giblin FJ, Lin LR, Chakrapani B. The effect of aqueous humor ascorbate on ultraviolet-B induced DNA damage in lens epithelium. Invest Ophthalm Vis Sci 1998; 39: 344-350. (Pubitemid 28093871)
18. Koliakos G, Konstas A, Schlötzer-Schrehardt U, Hollo G, Katsimbris I, Georgiadis N et al. 8-isoprostaglandin F2a and ascorbic acid concentration in the aqueous humor of patients with exfoliation syndrome. Br J Ophthalmol 2003; 87: 353-356. (Pubitemid 36307914)
19. Evelson P, Travacio M, Repetto M, Escobar M, Llesuy S, Lissi E. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 2001; 388: 261-266. (Pubitemid 32911618)
20. Ferreira S, Lerner F, Brunzini R, Evelson P, Llesuy S. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004; 137: 62-69. (Pubitemid 38045188)
21. Behnding A, Svensson B, Marklund S, Karisson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci 1998; 39: 471-475. (Pubitemid 28110677)
22. Cotagliola C, Iuliano G, Menzione M, Rinaldi E, Vito P, Auricchio G. Effect of vitamin E on glutathione content in red blood cells aqueous humor and lens of human and other species. Exp Eye Res 1986; 43: 905-914. (Pubitemid 17231170)
23. Martin Alonso J, Ghosh S, Coca Prados M. Cloning of bovine plasma selenium dependent glutathione peroxidase cDNA from the ocular ciliary epithelium. Expression of the plasma and cellular forms within the mammalian eye. Biochemistry 1993; 114: 284-291.
24. Quigley HA, West SK, Rodriguez J, Muñoz B, Klein R, Snyder R. The prevalence of glaucoma in a populationbased study of hispanic subjects. Arch Ophthalmol 2001; 119: 1819-1826. (Pubitemid 33139614)
25. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 2002; 86: 238-242. (Pubitemid 34127552)
26. Kyaw A. A simple colorimetric method for ascorbic acid determination in blood plasma. Clin Chim Acta 1978; 86: 153-157. (Pubitemid 8349344)
27. Lissi E, Pascual C, Del Castillo M. Luminol luminescence induced by 2,2-azo-bis (2-aminopropane) thermolysis. Free Rad Res Com 1992; 17: 299-311.
28. Flohé L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984; 105: 114-117.
29. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian tissues. Physiol Rev 1979; 59: 527-605.
30. Misra HP, Fridovich L. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-3175.
31. Koliakos G, Konstas A, Schlötzer-Scherardt U, Bufidis N, Ringvold A. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol 2002; 134: 879-883. (Pubitemid 35425457)
32. Yimaz A, Adigüzel U, Tamer L, Yildirim O, Oz O, Vatansever H et al. Serum oxidant/antioxidant balance in exfoliation syndrome. Clin Exp Ophthalmol 2005; 33: 63-66. (Pubitemid 40330978)
33. Packer JE, Slater TF, Willson RL. Kinetic study of the reaction of vitamin C with vitamin E radicals (tocopheroxyls) in solutions. Nature 1979; 278: 737-738.
34. Zhou L, Higginbotham E, Yuc B. Effects of ascorbic on levels of fibronectin, laminin and collagen type1 in bovine trabecular meshwork in organ culture. Curr Eye Res 1998; 17: 211-217. (Pubitemid 28073788)
35. Kinsey V. Transfer of ascorbic acid and related compounds across the blood-aqueous barrier. Am J Ophthalmol 1947; 30: 1262-1266.
36. Bleich S, Roedl J, Von Ahsen N, Schlötzer-Scherardt U, Reulbach U, Beck G et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Opthalmol 2004; 138: 162-164. (Pubitemid 38850275)
37. Bleich S, Junemann A, Von Ahsen N, Lausen B, Ritter K, Beck G et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm 2002; 109: 1499-1504.
38. Vessani R, Ritch R, Liebmann J, Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 2003; 136: 41-46. (Pubitemid 36794493)
39. Gartaganis SP, Georgakopoulos CD, Patsoukis NE, Gotsis S, Gartaganis V, Georgiou C. Glutathione and lipid peroxide changes in pseudoexfoliation syndrome. Curr Eye Res 2005; 30: 647-651. (Pubitemid 41306385)
40. Trachootham D, Lu W, Ogasawara M, Rivera-Del Valle N, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 2008; 10: 1343-1375.
41. Brown G. Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 1995; 232: 188-191.
42. Koliakos GG, Konstas A, Schlötzer-Schrehardt U, Hollo G, Mitova D, Kovatchev D et al. Endothelin-1 concentration is increased in aqueous humor of patients with exfoliation syndrome. Br J Ophthalmol 2004; 88: 523-527. (Pubitemid 38437874)
43. Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 2003; 114: 638-646. (Pubitemid 36703232)
44. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutation Res 2006; 612: 105-114.
45. Kumar DM, Agarwal N. Oxidative stress en glaucoma: a burden of evidence. J Glaucoma 2007; 16: 334-343. (Pubitemid 46626062)
46. Aslan M, Cort A, Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Rad Biol Med 2008; 45: 367-376.
47. Alvarado J, Murphy C, Polansky J, Juster R. Age related changes in trabecular meshwork cellularity. Invest Ophthalm Vis Sci 1981; 21: 714-727. (Pubitemid 12229217)
48. De la Paz M, Epstein D. Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest Ophthalm Vis Sci 1996; 37: 1849-1853. (Pubitemid 26265035)
49. Uçalhan O, Karel F, Kanpolat A, Deurime E, Durak I. Superoxide dismutase activity in the lens capsule of patients with pseudoexfoliation syndrome and cataract. J Cataract Refract Surg 2006; 32: 618-622. (Pubitemid 43673843)
50. Ophir A, Berenshtein E, Kitrossky N, Berman ER, Photiou S, Rothman Z et al. Hydroxyl radical generation in the cat retina during reperfusion following ischemia. Exp Eye Res 1993; 57: 351-357. (Pubitemid 23288814)